drugset / Trial / NCT05490381

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

NCT05490381 ↗

NaSingle-groupOpen-labelTreatment

Summary

This phase I trial tests whether embolization done prior to surgery (preoperative) will improve surgical outcomes in head and neck tumors with large amounts of blood vessels (hypervascular). Embolization is a minimally invasive surgical technique performed under angiographic (imaging of blood vessels) guidance. Embolization therapy injects tiny particles into the arteries feeding tumors to cut off their blood supply which may help improve outcomes by preventing blood loss during surgery, reducing surgical times, and shrinking tumors or reducing recurrence.

Timeline

Start
2023-12-21
Primary completion
2025-01-31
Completion
2025-01-31

Outcome

Outcome not reported

Stopped (Enrollment): “Study closed due to no accruals and change in the standard of care for this population”

Drugs

EvaluationDrugModalityDoseRoute
Subject Polyvinyl alcohol Unknown — Other
Subject lipiodol Unknown — Other

Indications